Title: Pierre Fabre – HEMANGEOL(TM) Home
Description: HEMANGEOLTM is the first and only FDA-approved treatment for proliferating infantile hemangioma requiring systemic therapy
Keywords:
Pierre Fabre,
infantile hemangioma,
Hemangeol,
hemangiomas in babies,
hemangiomas in infants,
oral propranolol,
pediatric hemangioma treatment,
propranolol for hemangiomas,
pediatric birthmarks,
vascular birthmarks of infancy,
HEMANGEOL